Literature DB >> 17940395

[An octogenarian case of postoperative recurrent lung cancer responding to treatments with radiation plus gefitinib].

Takaomi Hanaoka1, Shusuke Sone, Shinji Yamaguchi, Mitsuyo Okada, Toshihide Hayano.   

Abstract

An 82-year-old woman, a never smoker, had a radical operation for CT screening revealed lung cancer in an other hospital in 1997. She was admitted to our hospital complaining of dry cough and dyspnea on effort in March 2004. She was diagnosed to have a local recurrence of lung cancer 6 years after the operation. After she underwent radiotherapy of the mediastinum (total 60 Gy) and daily administration of gefitinib for two weeks, the administration of gefitinib was continued every other day in the outpatient clinic. During follow-up, CYFRA gradually increased to 3.8 ng/mL, but then decreased to the normal range. The tumor response rate of metastasized lymph nodes of bronchial bifurcation reached 36%, and it was confirmed to be a partial response. Without harmful phenomena except skin eruptions, her quality of life was good with a performance status (PS) 0 at 85 years 4 months of age, 9 years 2 months after the resection, with 2 years 5 months of gefitinib administration. It will be useful as a treatment option for octogenarians having postoperative recurrent lung cancers with every other day administration of gefitinib.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17940395

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  1 in total

1.  Successful treatment of EGFR-mutated non-small cell lung cancer with reduced-dose gefitinib: A case report.

Authors:  Hiroko Watanabe; Tomohiro Tamura; Katsunori Kagohashi; Norio Takayashiki; Koichi Kurishima; Hiroaki Satoh; Nobuyuki Hizawa
Journal:  Exp Ther Med       Date:  2015-05-18       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.